☰

David Lu, Ph.D. - Publications

Affiliations: 
Molecular Pathology University of California, San Diego, La Jolla, CA 
Area:
Pharmacology
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hosseiny M, Felker ER, Azadikhah A, Suvannarerg V, Sayre J, Ponzini D, Ahuja P, Lu D, Raman SS. Efficacy of 3T Multiparametric MR Imaging followed by 3T In-bore MR-Guided Biopsy for Detection of Clinically Significant Prostate Cancer Based on PIRADSv2.1 Score. Journal of Vascular and Interventional Radiology : Jvir. PMID 32921565 DOI: 10.1016/J.Jvir.2020.03.002  0.323
2020 Hosseiny M, Shakeri S, Felker ER, Lu D, Sayre J, Ahuja P, Raman SS. 3-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy. Ajr. American Journal of Roentgenology. 1-7. PMID 32755166 DOI: 10.2214/Ajr.19.22455  0.337
2019 Afshari Mirak S, Mohammadian Bajgiran A, Sung K, Asvadi NH, Markovic D, Felker ER, Lu D, Sisk A, Reiter RE, Raman SS. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2. Abdominal Radiology (New York). PMID 31549211 DOI: 10.1007/S00261-019-02234-6  0.328
2019 Krupa R, Richardson R, Ontiveros P, Schonhoft J, Byun J, Lu D, Nisperos S, Wang Y, Landers M, Dittamore R. Abstract 4039: Simultaneous quantification of activated immune cells and PD-L1 expressing circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy Cancer Research. 79: 4039-4039. DOI: 10.1158/1538-7445.Sabcs18-4039  0.308
2019 Byers LA, Stewart A, Heymach J, Fernandez L, Lu D, Rich R, Chu L, Wang Y, Dittamore R. Abstract 2215: SLFN11 and EZH2 protein expression and localization in circulating tumor cells to predict response or resistance to DNA damaging therapies in small cell lung cancer Cancer Research. 79: 2215-2215. DOI: 10.1158/1538-7445.Am2019-2215  0.327
2019 Johnson D, Raman S, Mirak S, Kwan L, Bajgiran A, Faeina I, Pooli A, Salmasi A, Sisk A, Felker E, Lu D, Reiter R. Mp30-04 Detection Of Individual Prostate Cancer Foci By Multiparametric Magnetic Resonance Imaging The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557559.05361.8A  0.351
2018 Afshari Mirak S, Shakeri S, Mohammadian Bajgiran A, Felker ER, Sung KH, Asvadi NH, Khoshnoodi P, Markovic D, Ponzini D, Ahuja P, Sisk A, Reiter RE, Lu D, Raman SS. 3T Multiparametric MRI: Comparison of Performance With and Without Endorectal Coil for Prostate Cancer Detection, PI-RADSv2 Category and Staging with Whole Mount Histopathology Correlation in 429 Patients. The Journal of Urology. PMID 30273608 DOI: 10.1016/J.Juro.2018.09.054  0.324
2018 Scher HI, Graf RP, Schreiber NA, Jayaram A, Winquist E, McLaughlin B, Lu D, Fleisher M, Orr S, Lowes L, Anderson A, Wang Y, Dittamore R, Allan AL, Attard G, et al. Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer. Jama Oncology. PMID 29955787 DOI: 10.1001/Jamaoncol.2018.1621  0.346
2018 Scher HI, Graf RP, Schreiber NA, Winquist E, McLaughlin B, Lu D, Orr S, Fleisher M, Lowes L, Anderson AKL, Wang Y, Dittamore RV, Allan AL, Attard G, Heller G. Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 36: 273-273. DOI: 10.1200/Jco.2018.36.6_Suppl.273  0.306
2018 Krupa R, Lu D, Jendrisak A, Rodriguez A, Ebrahim N, Richardson R, Nisperos S, Graf R, Byun J, Wang Y, Landers M, Dittamore R. Abstract 5536: Simultaneous characterization and quantification of immune cell subpopulations and PD-L1 expressing CTCs in peripheral blood of cancer patients Cancer Research. 78: 5536-5536. DOI: 10.1158/1538-7445.Am2018-5536  0.31
2018 Elkhoury F, Felker E, Kwan L, Raman S, Lu D, Shakeri S, Khoshnoodi P, White N, Karow D, Marks L. MP14-15 RESTRICTION SPECTRUM IMAGING IN PROSTATE CANCER DIAGNOSIS Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.508  0.31
2018 Bajgiran AM, Mirak SA, Felker E, Ahuja P, Maehara C, Hsu W, Lu D, Reiter R, Sisk A, Raman S. Mp40-07 3T Multiparametric Mri Based Detection Of Prostate Cancer: Features Of Detected And Missed Tumors Base On Pirads V2 In 429 Patients- Using Whole Mount Histopathology Reference The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1274  0.33
2017 Scher HI, Graf RP, Schreiber N, McLaughlin B, Jendrisak A, Wang Y, Lee J, Greene S, Krupa R, Lu D, Bamford P, Louw J, Dugan L, Vargas HA, Fleisher M, et al. Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer. Cancer Research. PMID 28819021 DOI: 10.1158/0008-5472.Can-17-1353  0.355
2017 Boffa DJ, Graf RP, Salazar MC, Hoag J, Lu D, Krupa R, Louw J, Dugan L, Wang Y, Landers M, Suraneni M, Greene SB, Makani S, Magaña M, Bazhenova L, et al. Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28446544 DOI: 10.1158/1055-9965.Epi-17-0120  0.314
2016 Scher HI, Graf RP, Schreiber NA, McLaughlin B, Lu D, Louw J, Danila DC, Dugan L, Johnson A, Heller G, Fleisher M, Dittamore R. Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer. European Urology. PMID 27979426 DOI: 10.1016/J.Eururo.2016.11.024  0.355
2016 Scher HI, Lu D, Schreiber NA, Louw J, Graf RP, Vargas HA, Johnson A, Jendrisak A, Bambury R, Danila D, McLaughlin B, Wahl J, Greene SB, Heller G, Marrinucci D, et al. Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer. Jama Oncology. PMID 27262168 DOI: 10.1001/Jamaoncol.2016.1828  0.337
2016 Boffa DJ, Nieva JJ, Bazhenova L, Krupa R, Lu D, Graf R, Louw J, Dugan L, Jendrisak A, Salazar M, Makani S, Magana M, Orr S, Bethel K, Wang Y, et al. Programmed cell death-1 ligand (PD-L1) expression on circulating CD45(-) cells is an independent prognostic factor for overall survival in patients (Pts) with lung cancer in a prospective, multicenter cohort. Journal of Clinical Oncology. 34: 8524-8524. DOI: 10.1200/Jco.2016.34.15_Suppl.8524  0.316
2016 Anantharaman A, Friedlander TW, Lu D, Krupa R, Premasekharan G, Hough J, Edwards M, Graf R, Jendrisak A, Louw J, Dugan L, Marrinucci DC, Dittamore RV, Paris P. Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients. Journal of Clinical Oncology. 34: 4527-4527. DOI: 10.1200/Jco.2016.34.15_Suppl.4527  0.3
2016 Scher HI, Lu D, Schreiber NA, Louw J, Graf RP, Johnson A, Jendrisak A, Heller G, Bambury R, Alverez HAV, McLaughlin B, Wahl J, Greene S, Fleisher M, Dittamore R. Abstract 4954: Nuclear localized AR-V7 protein as a predictive biomarker for treatment selection in metastatic castration resistant prostate cancer (mCRPC) Cancer Research. 76: 4954-4954. DOI: 10.1158/1538-7445.Am2016-4954  0.312
2016 wibulpolprasert p, Raman SS, Khoshnoodi P, Yu W, Hsu W, Tan N, Huang J, Lu D, Margolis DJ, Reiter R. Mp53-05 Performance Of 3T Multiparameteric Mri In Diagnosis Of Prostate Cancer In Comparison With Whole Mount Histopathology: A 5 Year Experience The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.502  0.306
2015 Scher HI, Louw J, Jendrisak A, Bambury RM, Danila DC, Rathkopf DE, Arslan Z, Schreiber NA, Lu D, Krupa R, Marrinucci D, Landers M, Dittamore RV. Predictive biomarkers of sensitivity to androgen receptor signaling (ARS) and taxane-based chemotherapy in circulating tumor cells (CTCs) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 33: 147-147. DOI: 10.1200/Jco.2015.33.7_Suppl.147  0.305
2015 Palapattu GS, Cani AK, Huang J, Hovelson DH, Lu D, Margolis D, Natarajan S, Mehra R, Montgomery JS, Morgan TM, Tomlins SA, Marks LS. Progression of low- to high-grade prostate cancer: Molecular profiling of tissue obtained by serial targeted biopsy. Journal of Clinical Oncology. 33: 5017-5017. DOI: 10.1200/Jco.2015.33.15_Suppl.5017  0.331
2015 Kelvin J, Lu D, Packer D, Bambury R, Rathkopf D, Schreiber N, Arslan Z, Prigozhina N, Brown D, Krupa R, Swangren E, Landers M, Lee F, Marrinucci D, Dittamore R, et al. Abstract 1588: Single cell analysis of AR N terminal, AR C terminal and the ARv7 splice variant in the CTCs of metastatic castration resistant prostate cancer (mCRPC) patients Cancer Research. 75: 1588-1588. DOI: 10.1158/1538-7445.Am2015-1588  0.307
2015 Lu D, Harvey M, Madan R, Heery C, Marte J, Beasley S, Landers M, Krupa R, Louw J, Wahl J, Bales N, Marrinucci D, Schlom J, Gulley J, Dittamore R. Abstract 1586: Recovery and characterization of circulating tumor cells (CTCs) in cryopreserved metastatic castrate-resistant prostate cancer (mCRPC) patient samples Cancer Research. 75: 1586-1586. DOI: 10.1158/1538-7445.Am2015-1586  0.314
2015 Felker E, Lee-Felker S, Feller J, May S, Princenthal R, Cohen M, Lu D, Margolis D, Kim G, Raman S. Pd38-08 Performance Of In-Bore Mr-Guided Targeted Prostate Biopsy For Detection Of Clinically Significant Prostate Cancer: A Multicenter Study The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2429  0.322
2015 Lin WC, Tan N, Khoshnoodi P, Margolis D, Lu D, Raman S. Mp86-19 In-Bore Mri-Guided Targeted Prostate Biopsy (Mrgtbx): Pi Rads Based Prostate Cancer Detection And Gleason Upgrading On 3T Compared To Trus Biopsy In Men With Elevated Psa The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1928  0.318
2014 Lu D, Insel PA. Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis. American Journal of Physiology. Cell Physiology. 306: C779-88. PMID 24352335 DOI: 10.1152/Ajpcell.00381.2013  0.475
2014 Lu D, Krupa R, Bales N, Louw J, Marrinucci D, Dittamore R. Abstract 2841: Characterization of ALK fusions in circulating tumor cells (CTCs) of NSCLC Cancer Research. 74: 2841-2841. DOI: 10.1158/1538-7445.Am2014-2841  0.326
2014 Tan N, Le J, Margolis D, Lu D, King K, Robert R, Raman S. Mp67-02 Prostate Cancer Missed By Multi-Parametric Mri: Correlation With Whole-Mount Pathology The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2069  0.314
2013 Lu D, Aroonsakool N, Yokoyama U, Patel HH, Insel PA. Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis. Molecular Pharmacology. 84: 787-93. PMID 24085841 DOI: 10.1124/Mol.113.087742  0.593
2013 Lu D, Insel PA. Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts. The Journal of Biological Chemistry. 288: 19040-9. PMID 23677997 DOI: 10.1074/Jbc.M113.466102  0.467
2012 Lu D, Soleymani S, Madakshire R, Insel PA. ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2580-91. PMID 22415310 DOI: 10.1096/Fj.12-204677  0.462
2012 Insel PA, Murray F, Yokoyama U, Romano S, Yun H, Brown L, Snead A, Lu D, Aroonsakool N. cAMP and Epac in the regulation of tissue fibrosis. British Journal of Pharmacology. 166: 447-56. PMID 22233238 DOI: 10.1111/J.1476-5381.2012.01847.X  0.48
2010 Braun OO, Lu D, Aroonsakool N, Insel PA. Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors Journal of Molecular and Cellular Cardiology. 49: 362-369. PMID 20471392 DOI: 10.1016/J.Yjmcc.2010.05.001  0.457
Show low-probability matches.